These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 23170962)

  • 1. The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast.
    Mesa-Arango AC; Forastiero A; Bernal-Martínez L; Cuenca-Estrella M; Mellado E; Zaragoza O
    Med Mycol; 2013 Jul; 51(5):461-72. PubMed ID: 23170962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence of Candida haemulonii complex in Galleria mellonella and efficacy of classical antifungal drugs: a comparative study with other clinically relevant non-albicans Candida species.
    Silva LN; Campos-Silva R; Ramos LS; Trentin DS; Macedo AJ; Branquinha MH; Santos ALS
    FEMS Yeast Res; 2018 Nov; 18(7):. PubMed ID: 30052907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis.
    Mylonakis E; Moreno R; El Khoury JB; Idnurm A; Heitman J; Calderwood SB; Ausubel FM; Diener A
    Infect Immun; 2005 Jul; 73(7):3842-50. PubMed ID: 15972469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida isolates causing candidemia show different degrees of virulence in Galleria mellonella.
    Marcos-Zambrano LJ; Bordallo-Cardona MÁ; Borghi E; Falleni M; Tosi D; Muñoz P; Escribano P; Guinea J
    Med Mycol; 2020 Jan; 58(1):83-92. PubMed ID: 30874807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galleria mellonella as an alternative in vivo model to study implant-associated fungal infections.
    Mannala GK; Rupp M; Walter N; Scholz KJ; Simon M; Riool M; Alt V
    J Orthop Res; 2023 Nov; 41(11):2547-2559. PubMed ID: 37080929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
    Warn PA; Sharp A; Morrissey G; Denning DW
    J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment.
    Maurer E; Hörtnagl C; Lackner M; Grässle D; Naschberger V; Moser P; Segal E; Semis M; Lass-Flörl C; Binder U
    Med Mycol; 2019 Apr; 57(3):351-362. PubMed ID: 29924357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galleria mellonella as a model for fungal pathogenicity testing.
    Fallon J; Kelly J; Kavanagh K
    Methods Mol Biol; 2012; 845():469-85. PubMed ID: 22328396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the efficacy of antifungal drugs against Paracoccidioides brasiliensis and Paracoccidioides lutzii in a Galleria mellonella model.
    de Lacorte Singulani J; Scorzoni L; de Paula E Silva AC; Fusco-Almeida AM; Mendes-Giannini MJ
    Int J Antimicrob Agents; 2016 Sep; 48(3):292-7. PubMed ID: 27444116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile.
    Scorzoni L; de Lucas MP; Mesa-Arango AC; Fusco-Almeida AM; Lozano E; Cuenca-Estrella M; Mendes-Giannini MJ; Zaragoza O
    PLoS One; 2013; 8(3):e60047. PubMed ID: 23555877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galleria mellonella as a host model to study Aspergillus terreus virulence and amphotericin B resistance.
    Maurer E; Browne N; Surlis C; Jukic E; Moser P; Kavanagh K; Lass-Flörl C; Binder U
    Virulence; 2015; 6(6):591-8. PubMed ID: 26107350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation of a Gaussia princeps Luciferase reporter system in Candida albicans for in vivo detection in the Galleria mellonella infection model.
    Delarze E; Ischer F; Sanglard D; Coste AT
    Virulence; 2015; 6(7):684-93. PubMed ID: 26305489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic switching in Candida tropicalis alters host-pathogen interactions in a Galleria mellonella infection model.
    Perini HF; Moralez ATP; Almeida RSC; Panagio LA; Junior AOG; Barcellos FG; Furlaneto-Maia L; Furlaneto MC
    Sci Rep; 2019 Aug; 9(1):12555. PubMed ID: 31467372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galleria mellonella as an in vivo model for assessing the efficacy of antimicrobial agents against Enterobacter cloacae infection.
    Yang HF; Pan AJ; Hu LF; Liu YY; Cheng J; Ye Y; Li JB
    J Microbiol Immunol Infect; 2017 Feb; 50(1):55-61. PubMed ID: 25682237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced virulence of melanized Cryptococcus neoformans in Galleria mellonella.
    Eisenman HC; Duong R; Chan H; Tsue R; McClelland EE
    Virulence; 2014 Jul; 5(5):611-8. PubMed ID: 24846144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to amphotericin B in clinical isolates of Candida tropicalis.
    Barchiesi F; Maracci M; Baldassarri I; Spreghini E; Giannini D; Scalise G
    Diagn Microbiol Infect Dis; 2004 Nov; 50(3):179-85. PubMed ID: 15541603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Galleria mellonella larvae for measuring the efficacy and pharmacokinetics of antibiotic therapies against Pseudomonas aeruginosa infection.
    Hill L; Veli N; Coote PJ
    Int J Antimicrob Agents; 2014 Mar; 43(3):254-61. PubMed ID: 24361354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents.
    Li DD; Deng L; Hu GH; Zhao LX; Hu DD; Jiang YY; Wang Y
    Biol Pharm Bull; 2013; 36(9):1482-7. PubMed ID: 23995660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galleria mellonella as a model host to study Paracoccidioides lutzii and Histoplasma capsulatum.
    Thomaz L; García-Rodas R; Guimarães AJ; Taborda CP; Zaragoza O; Nosanchuk JD
    Virulence; 2013 Feb; 4(2):139-46. PubMed ID: 23302787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of the EUCAST Trailing Phenomenon in Candida tropicalis for the
    Astvad KMT; Sanglard D; Delarze E; Hare RK; Arendrup MC
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.